Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …
to estimate the association of treatment success and death with the use of individual drugs …
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
Background The results of some reports have suggested that treatment of isoniazid-resistant
tuberculosis with the recommended regimens of first-line drugs might be suboptimal. We …
tuberculosis with the recommended regimens of first-line drugs might be suboptimal. We …
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-
based methods being considered the gold standard for drug susceptibility testing, molecular …
based methods being considered the gold standard for drug susceptibility testing, molecular …
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
F Fregonese, SD Ahuja, OW Akkerman… - The lancet respiratory …, 2018 - thelancet.com
Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most
common form of drug resistance, and is associated with failure, relapse, and acquired …
common form of drug resistance, and is associated with failure, relapse, and acquired …
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement
The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …
global tuberculosis (TB) control. Although culture-based methods have been regarded as …
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
ML Bastos, Z Lan, D Menzies - European Respiratory …, 2017 - publications.ersnet.org
This systematic review aimed to update the current evidence for multidrug-resistant
tuberculosis (MDR-TB) treatment. We searched for studies that reported treatment …
tuberculosis (MDR-TB) treatment. We searched for studies that reported treatment …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
Background Current anti-tuberculosis therapeutics are not sufficiently effective against drug-
resistant tuberculosis (DR-TB), and there is a need for new drugs and therapeutic …
resistant tuberculosis (DR-TB), and there is a need for new drugs and therapeutic …
Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Bei**g Strains in Patients
Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains represent a
major threat for tuberculosis (TB) control. Treatment of MDR-TB patients is long and less …
major threat for tuberculosis (TB) control. Treatment of MDR-TB patients is long and less …
Acquired drug resistance in Mycobacterium tuberculosis and poor outcomes among patients with multidrug-resistant tuberculosis
Rates and risk factors for acquired drug resistance and association with outcomes among
patients with multidrug-resistant tuberculosis (MDR TB) are not well defined. In an MDR TB …
patients with multidrug-resistant tuberculosis (MDR TB) are not well defined. In an MDR TB …